Gufic Biosciences share news, announcements and annual reports
NSE: GUFICBIOBSE: 509079Pharmaceuticals & BiotechnologySmall Cap
Gufic Biosciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1985 on BSE, Oct 2004 on NSE
Last close ₹418.80down ₹4.95 (1.17%)BSE ₹420.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹423.75.
29 Oct: open ₹423.00, high ₹424.05, low ₹416.25
52-week range of traded prices to 29 Oct 2026
₹268.00Low, 9 Mar 2026₹467.80High, 7 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,200 Cr959th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 57.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.32
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 26,73756.8% delivered
Gufic Biosciences routine notices
124 filed, newest first. Page 2 of 3.
Jul 2024
1 Jul · Routine
Jun 2024
10 Jun · Routine
May 2024
31 May · Routine
10 May · Routine
Apr 2024
Mar 2024
Feb 2024
23 Feb · Routine
16 Feb · Routine
6 Feb · Routine
Jan 2024
Dec 2023
14 Dec · Routine
Nov 2023
10 Nov · Routine
Oct 2023
Sep 2023
8 Sep · Routine
2 Sep · Routine
Aug 2023
Jul 2023
Jun 2023
7 Jun · Routine
May 2023
Apr 2023
Mar 2023
Jan 2023
31 Jan · Routine
Dec 2022
Sep 2022
29 Sep · Routine
Aug 2022
Jun 2022
29 Jun · Routine
May 2022
24 May · Routine
Mar 2022
31 Mar · Routine
Jan 2022
Dec 2021
21 Dec · Routine
Oct 2021
Sep 2021
Aug 2021
30 Aug · Routine
29 Aug · Routine
28 Aug · Routine
Jul 2021
Jun 2021
18 Jun · Routine
Apr 2021